Kestra Medical Technologies (KMTS) Operating Leases (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Operating Leases data on file, last reported at $4.3 million in Q1 2026.

• Quarterly Operating Leases rose 49.41% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $4.3 million (up 49.41% YoY) and the FY2025 annual result came in at $3.0 million, up 14.93% from the prior year.
• Operating Leases climbed to $4.3 million in Q1 2026 per KMTS's latest filing, from $2.9 million in the prior quarter.
• Across five years, Operating Leases topped out at $4.3 million in Q1 2026 and bottomed at $2.6 million in Q2 2024.
• The 3-year median for Operating Leases is $2.9 million (2025), against an average of $3.1 million.
• The widest annual swing landed in 2025, when Operating Leases advanced 14.93%; it then soared 49.41% in 2026.
• Tracing KMTS's Operating Leases over 3 years: stood at $2.6 million in 2024, then grew by 9.15% to $2.9 million in 2025, then soared by 48.78% to $4.3 million in 2026.
• Per Business Quant, the three latest KMTS Operating Leases figures stand at $4.3 million (Q1 2026), $2.9 million (Q4 2025), and $3.1 million (Q3 2025).

Peer Comparison